Apremilast in Psoriatic Arthritis in Real-life Clinical Practice in Greece

Clinical trial NCT03780504 · UNKNOWN

Trial details

NCT number: NCT03780504
Sponsor: Genesis Pharma S.A.
Status: UNKNOWN
Study type: OBSERVATIONAL

Psoriatic Arthritis

Start date: 2019-04-15
Primary completion: 2021-07-20
Enrollment: 170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.